Latest Videos
Health care professionals provide their considerations regarding the future of measles prevention and management.
Tristan Ferry, MD, PhD, discusses why there is a need to develop alternatives to treat chronic bone and joint infections.
Investigators found increased mortality in the combination arm where 21% of patients died vs 16% in the standard therapy arm, although the number of patients with persistent bacteremia at day 5 in the combination arm was significantly reduced compared wit
Will biomarker-guided specific therapies the best option for treating sepsis in the future?
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.